Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$290,687
-$77,806 QoQ
Shares Held
12,072
-8.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#2,147
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Wealth Management LLC holds $7,869,904 across 14 Drug Manufacturers - General names. PFE ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,276 | $2,334,208 | |
| 2 | JNJ |
Johnson & Johnson
|
8,486 | $2,155,180 | |
| 3 | NVS |
Novartis AG
|
6,045 | $947,369 | |
| 4 | AMGN |
Amgen Inc
|
1,542 | $558,386 | |
| 5 | LLY |
ELI LILLY & Co
|
370 | $443,788 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,329 | $307,055 | |
| 7 | PFE |
Pfizer Inc
This page
|
12,072 | $290,687 | |
| 8 | NVO |
Novo Nordisk A S
|
4,946 | $237,111 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $290,687 | 12,072 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $368,493 | 13,123 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $326,712 | 13,121 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $361,816 | 14,200 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $349,589 | 14,422 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $380,226 | 15,005 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $408,641 | 15,403 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $587,539 | 20,302 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $554,731 | 19,826 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $582,056 | 20,975 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $653,561 | 22,701 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $762,644 | 22,992 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $843,309 | 22,991 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $937,992 | 22,990 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,412,379 | 27,564 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,005,954 | 22,988 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,208,354 | 23,047 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,200,132 | 23,182 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,351,182 | 22,882 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $963,165 | 22,394 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $906,945 | 23,160 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $839,086 | 23,160 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $866,838 | 23,549 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $822,446 | 22,410 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $743,598 | 22,740 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $616,079 | 18,875 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||